Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria Mochly-Rosen

Showing results (71-80 of 244) with videos related to

Pageof 25
Sort By:
Biochemical and Biophysical Research Communications|November 23, 2006
Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cellsVidya Mamidipudi, Laura D Miller, Daria Mochly-Rosen, et al.
Cell Reports|March 16, 2017
Coupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD VariantsAnna D Cunningham, Alexandre Colavin, Kerwyn Casey Huang, et al.
Oncotarget|February 22, 2018
Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's diseaseAmit U Joshi, Nay L Saw, Mehrdad Shamloo, et al.
Biomolecules|October 23, 2021
Annotation of 1350 Common Genetic Variants of the 19 ALDH Multigene Family from Global Human Genome Aggregation Database (gnomAD)Che-Hong Chen, Benjamin R Kraemer, Lucia Lee, et al.
Communications Biology|March 15, 2026
Increased susceptibility to 4-HNE-induced toxicity and impaired development in a model of ALDH4A1-deficient pediatric epilepsy carrying the S352L variantBenjamin R Kraemer, Gwangbeom Heo, Che-Hong Chen, et al.
Circulation|July 16, 2003
Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activatorKoichi Inagaki, Harvey S Hahn, Gerald W Dorn, et al.
The Journal of Biological Chemistry|June 21, 2006
Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and functionViktoria Kheifets, Rachel Bright, Koichi Inagaki, et al.
The Journal of Biological Chemistry|May 9, 2013
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) phosphorylation by protein kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injuryGouri Yogalingam, Sunhee Hwang, Julio C B Ferreira, et al.
Journal of Molecular and Cellular Cardiology|November 17, 2009
deltaPKC inhibition or varepsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modificationMartina Monti, Sandra Donnini, Antonio Giachetti, et al.
Trends in Pharmacological Sciences|August 14, 2021
Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectivesAdriana A Garcia, Ana Koperniku, Julio C B Ferreira, et al.
Pageof 25

Showing results (71-80 of 244) with videos related to

Sort By:
Pageof 25
Biochemical and Biophysical Research Communications|November 23, 2006
Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cellsVidya Mamidipudi, Laura D Miller, Daria Mochly-Rosen, et al.
Cell Reports|March 16, 2017
Coupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD VariantsAnna D Cunningham, Alexandre Colavin, Kerwyn Casey Huang, et al.
Oncotarget|February 22, 2018
Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's diseaseAmit U Joshi, Nay L Saw, Mehrdad Shamloo, et al.
Biomolecules|October 23, 2021
Annotation of 1350 Common Genetic Variants of the 19 ALDH Multigene Family from Global Human Genome Aggregation Database (gnomAD)Che-Hong Chen, Benjamin R Kraemer, Lucia Lee, et al.
Communications Biology|March 15, 2026
Increased susceptibility to 4-HNE-induced toxicity and impaired development in a model of ALDH4A1-deficient pediatric epilepsy carrying the S352L variantBenjamin R Kraemer, Gwangbeom Heo, Che-Hong Chen, et al.
Circulation|July 16, 2003
Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activatorKoichi Inagaki, Harvey S Hahn, Gerald W Dorn, et al.
The Journal of Biological Chemistry|June 21, 2006
Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and functionViktoria Kheifets, Rachel Bright, Koichi Inagaki, et al.
The Journal of Biological Chemistry|May 9, 2013
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) phosphorylation by protein kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injuryGouri Yogalingam, Sunhee Hwang, Julio C B Ferreira, et al.
Journal of Molecular and Cellular Cardiology|November 17, 2009
deltaPKC inhibition or varepsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modificationMartina Monti, Sandra Donnini, Antonio Giachetti, et al.
Trends in Pharmacological Sciences|August 14, 2021
Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectivesAdriana A Garcia, Ana Koperniku, Julio C B Ferreira, et al.
Pageof 25